Experimental autoimmune autonomic neuropathy

Journal of Neurophysiology

Volumn 90, Issue 3, 2003, Pages 2053-2059

  Vernino, Steven ^a   Low, Phillip A ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FEMALE; HEART RATE; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RABBITS; RECEPTORS, NICOTINIC; TEARS;

EID: 0141565066     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00408.2003     Document Type: Article

References (23)

1. Anderson NE, Hutchinson DO, Nicholson GJ, Aitcheson F, and Nixon JM. Intestinal pseudo-obstruction, myasthenia gravis, and thymoma. Neurology 47: 985-987, 1996.
2. Condom E, Vidal A, Rota R, Graus F, Dalmau J, and Ferrer I. Paraneo-plastic intestinal pseudo-obstruction associated with high titres of Hu auto-antibodies. Virchows Archiv A Pathol Anat Histopathol 423: 507-511, 1993.
3. Drachman DB, Angus CW, Adams RN, Michelson JD, and Hoffman GJ. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 298: 1116-1122, 1978.
4. Fairman CL, Clagett-Dame M, Lennon VA, and Epstein ML. Appearance of neurons in the developing chick gut. Dev Dyn 204: 192-201, 1995.
5. Goldstein D, Eisenhofer G, Stull R, Folio C, Keiser H, and Kopin I. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest 81: 213-220, 1988.
6. Klein C, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L,. Sletten D, and Low PA. The spectrum of autoimmune autonomic neuropathies. Ann Neurol 53: 752-758, 2003.
7. Lennon VA. Immunofluorescence analysis of surface acetylcholine receptors on muscle: modulation by auto-antibodies. In: Cholinergic Mechanisms and Psychopharmacology, edited by Jenden DJ. New York: Plenum. 1977, p. 77-91.
8. Lennon VA, Ermilov LG, Szurszewski JH, and Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111: 907-913, 2003.
9. Lennon VA and Lambert EH. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285: 238-240, 1980.
10. Lennon VA and Lambert EH. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann NY Acad Sci 377: 77-96, 1981.
11. Lennon VA, Lindstrom JM, and Seybold ME. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J Exp Med 141: 1365-1375, 1975.
12. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, and Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 100: 137-142, 1991.
13. Novak P and Novak V. Time/frequency mapping of the heart rate, blood pressure and respiratory signals. Med Biol Eng Comput 31: 103-110, 1993.
14. Patrick J and Lindstrom J. Autoimmune response to acetylcholine receptors. Science 180: 871-872, 1973.
15. Patrick J, Sequela P, Vernino S, Amador M, Luetje C, and Dani JA. Functional diversity of neuronal nicotinic acetylcholine receptors, Prog Brain Res 98: 113-120, 1993.
16. Patrick J and Stallcup WB. Immunological distinction between acetylcholine receptor and the alpha-bungarotoxin-binding component on sympathetic neurons. Proc Natl Acad Sci USA 74: 4689-4692, 1977.
17. Schoepfer R, Halvorsen SW, Conroy WG, Whiting P, and Lindstrom J. Antisera against an acetylcholine receptor α3 fusion protein bind to ganglionic but not to brain nicotinic acetylcholine receptors. FEBS Lett 257: 393-399, 1989.
18. Suarez GA, Fealey RD, Camilleri M, and Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 44: 1675-1682, 1994.
19. Tuininga YS, Crijns HJ, Brouwer J, van den Berg MP, Man in't Veld AJ, Mulder G, and Lie KI. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients. Circulation 92: 3415-3423, 1995.
20. Vernino S, Adamski J, Kryzer TJ, Fealey RD, and Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50: 1806-1813, 1998.
21. Vernino S, Kryzer T, and Lennon V. Autoantibodies in autoimmune autonomic neuropathies and neuromuscular hyperexcitability disorders. In: Manual of Clinical Laboratory Immunology, edited by Rose N, Hamilton R, and Detrick B. Washington, DC: ASM Press, 2002, p. 1013-1017.
22. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, and Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343: 847-855, 2000.
23. Xu W, Gelber S, Orr-Urtreger A, Armstrong D, Lewis RA, Ou CN, Patrick J, Role L, De Biasi M, and Beaudet AL. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 96: 5746-5751, 1999.